Functional loss of MED14 not only inhibits pre-adipocyte differentiation but also improves insulin resistance and dyslipidemia in animal models, providing a new strategy for obesity treatment. This evidence concerns the gene MED14 and obesity due to melanocortin 4 receptor deficiency.